Clinician Input and Feedback

Clinician group input is used by us in all phases of the review, including the development of the review protocol, appraisal of evidence, and interpretation of the results. The clinician group input summary and individual submissions are included in the committee briefing materials.

Input from clinicians is submitted to us by groups or associations of health care professionals. Individual clinicians who wish to provide input are encouraged to work with a group that represents their profession to prepare a group submission. We will accept input from individual clinicians only when there is no relevant group or association that could provide input for the drug under review. Individuals who wish to submit input for a drug review should first contact us (at [email protected]) to confirm the absence of a relevant group or association.

Reimbursement Reviews

Steps for Providing Clinician Input

The call for clinician input regarding a pending application is posted 29 business days in advance of the anticipated filing date. Groups or associations of health care professionals will have a total of 35 business days to prepare and submit their input. We send out notifications for these open calls every Thursday, through its Weekly Summary . Calls for clinician input are also highlighted on the open calls page of the our website.

To participate:

• Download the Clinician group input template
• Complete the template by the deadline given on the Open Calls page.
• Ensure that all contributing clinicians have completed the conflict of interest declaration in the clinician input template. Input will not be accepted without the conflict of interest section completed for all contributors.
• Send the completed template by using the Submit link next to the drug listed on the Open Calls page. The input must be filed as a Microsoft Word document by the posted deadline date for the information to be used by us.

Steps for Providing Feedback on Draft Recommendations

Following our review and expert committee deliberations, draft reimbursement recommendations are shared for feedback. New draft recommendations and open calls for feedback are highlighted in the Weekly Summary.

To participate:

• Download the template: feedback on draft recommendation
• Complete the feedback form by the deadline on the Open Calls page.
• Submit the completed form by using the Submit link next to the drug on the Open Calls page.

Provisional Funding Algorithms for Oncology Drugs

Steps for Providing Clinician Input

We issue a call for stakeholder input for all provisional funding algorithm projects. Open calls for input are highlighted in the Weekly Summary.

To provide initial input at the outset of the provisional funding algorithm project:

• Locate the webpage for provisional algorithm project of interest from the Weekly Summary or the list of current opportunities for input and feedback.
• Review the proposed project scope for the provisional algorithm.
• Download the input template.
• Complete the template by the deadline specified on the project webpage.
• Send the completed template by clicking Submit Feedback on the project webpage.

Steps for Providing Feedback

We issue a call for stakeholder feedback on all draft provisional funding algorithms. Open calls for feedback are highlighted in the Weekly Summary.

To provide  feedback on a draft provisional funding algorithm:

• Locate the webpage for provisional algorithm project of interest from the Weekly Summary Update or the list of current opportunities for input and feedback.
• Review the draft provisional funding algorithm report.
• Download the feedback template.
• Complete the template by the deadline specified on the project webpage.
• Send the completed template by clicking Submit Feedback on the project webpage.

Questions and Comments

If you have questions or need help to participate, please contact [email protected].

To learn more about our reimbursement review process, you can to the Procedures for Reimbursement Reviews.